BACKGROUND: Photodynamic therapy is an attractive technique for mucosal ablation in patients with superficial squamous cell carcinoma of the esophagus, or high-grade dysplasia or early stage adenocarcinoma arising in Barrett's esophagus. Although illumination with green light is assumed to be safe, choice of the light has been empirical in clinical studies; light dose is often reduced to avoid potential complications. The present study assessed the safety of green and blue lights during photodynamic therapy in the esophagus by progressively administrating increasing doses in an attempt to standardize the dose and determine a safe upper limit. This would considerably simplify photodynamic therapy and improve therapeutic results. METHODS: The...
BACKGROUND AND STUDY AIMS: The methods of endoscopic ablation of metaplastic and dysplastic areas in...
The optimal drug-light interval for effective photodynamic therapy (PDT) of early squamous cell carc...
Pancreatic cancer kills over 1700 people each year in Australia. In 2000, there were1908 new cases d...
BACKGROUND: Photodynamic therapy is an attractive technique for mucosal ablation in patients with su...
Background and Objectives: Precursor lesions of oesophagus adenocarcinoma constitute a clinical dile...
Background and Objective: Photodynamic therapy (PDT) may be used for ablation of high grade dysplasi...
BACKGROUND AND OBJECTIVE: Photodynamic therapy (PDT) is an efficient technique to treat superficial ...
BACKGROUND: Treatment failure at the primary site after chemoradiotherapy is a major problem in achi...
Treatment failure at the primary site after chemoradiotherapy is a major problem in achieving a comp...
Bringing laser-induced thermal therapy to gastroenterology and accepting it as a traditional method ...
Barrett’s esophagus is associated with an increased occurrence of mucosal dysplasia and adenocarcino...
Objectives The transfer and widespread acceptance of laser-induced thermal therapy into gastroentero...
OBJECTIVE: To clinically evaluate a new photosensitizer, m-tetra(hydroxyphenyl) chlorin (m-THPC), fo...
Objective: To clinically evaluate a new photosensitizer, m- tetra(hydroxyphenyl) chlorin (m-THPC), f...
textabstractBackground and Objectives: Previous studies with PhotoDynamic Therapy (PDT) in bladder a...
BACKGROUND AND STUDY AIMS: The methods of endoscopic ablation of metaplastic and dysplastic areas in...
The optimal drug-light interval for effective photodynamic therapy (PDT) of early squamous cell carc...
Pancreatic cancer kills over 1700 people each year in Australia. In 2000, there were1908 new cases d...
BACKGROUND: Photodynamic therapy is an attractive technique for mucosal ablation in patients with su...
Background and Objectives: Precursor lesions of oesophagus adenocarcinoma constitute a clinical dile...
Background and Objective: Photodynamic therapy (PDT) may be used for ablation of high grade dysplasi...
BACKGROUND AND OBJECTIVE: Photodynamic therapy (PDT) is an efficient technique to treat superficial ...
BACKGROUND: Treatment failure at the primary site after chemoradiotherapy is a major problem in achi...
Treatment failure at the primary site after chemoradiotherapy is a major problem in achieving a comp...
Bringing laser-induced thermal therapy to gastroenterology and accepting it as a traditional method ...
Barrett’s esophagus is associated with an increased occurrence of mucosal dysplasia and adenocarcino...
Objectives The transfer and widespread acceptance of laser-induced thermal therapy into gastroentero...
OBJECTIVE: To clinically evaluate a new photosensitizer, m-tetra(hydroxyphenyl) chlorin (m-THPC), fo...
Objective: To clinically evaluate a new photosensitizer, m- tetra(hydroxyphenyl) chlorin (m-THPC), f...
textabstractBackground and Objectives: Previous studies with PhotoDynamic Therapy (PDT) in bladder a...
BACKGROUND AND STUDY AIMS: The methods of endoscopic ablation of metaplastic and dysplastic areas in...
The optimal drug-light interval for effective photodynamic therapy (PDT) of early squamous cell carc...
Pancreatic cancer kills over 1700 people each year in Australia. In 2000, there were1908 new cases d...